The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat.
Hugo A Tejeda, Vladimir I Chefer, Agustin Zapata, Toni S Shippenberg
Psychopharmacology June 2010 DOI: 10.1007/s00213-010-1799-6 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Preclinical experimental study in rats Peer reviewed |
|---|---|
| Population | Rats |
| Interventions | (+/-) U50 488 (-) U50 U69 593 Salvinorin A nor-binaltorphimine (nor-BNI) MK-801 quinpirole corticotropin-releasing factor (CRF) |
| Measures | prepulse inhibition of the acoustic startle reflex (PPI), startle reactivity |
| Key findings | KOR activation by several agonists and KOR blockade by nor-binaltorphimine did not alter prepulse inhibition or startle reactivity in rats, whereas MK-801 and quinpirole did disrupt PPI. CRF infusion decreased PPI, but nor-BNI did not affect this CRF-evoked disruption. The authors conclude these results provide no evidence of a link between the dynorphin/KOR system and sensory gating deficits. |
Abstract
Kappa-opioid receptor (KOR) agonists produce dysphoria and psychotomimesis in humans. KORs are enriched in the prefrontal cortex and other brain regions that regulate mood and cognitive function. Dysregulation of the dynorphin/KOR system has been implicated in the pathogenesis of schizophrenia, depression, and bipolar disorder. Prepulse inhibition of the acoustic startle reflex (PPI), a sensorimotor gating process, is disrupted in many psychiatric disorders. The present study determined whether KOR ligands alter PPI in rats. Utilizing a range of doses of the synthetic KOR agonists (+/-) U50,488, (-) U50,488, and U69,593 and the naturally occurring KOR agonist, Salvinorin A, we demonstrate that KOR activation does not alter PPI or startle reactivity in rats. Similarly, selective KOR blockade using the long-acting antagonist nor-binaltorphimine (nor-BNI) was without effect. In contrast to KOR ligands, MK-801 and quinpirole produced deficits in PPI. Stress and corticotropin-releasing factor (CRF) decrease PPI levels. The dynorphin/KOR system has been suggested to be a key mediator of various behavioral effects produced by stress and CRF. We therefore examined the contribution of KORs to CRF-induced alterations in PPI. Intracerebroventricular infusion of CRF decreased PPI. Administration of nor-BNI failed to affect the CRF-evoked disruption in PPI. Together, these results provide no evidence of a link between the dynorphin/KOR system and deficits in sensory gating processes. Additional studies, however, examining whether dysregulation of this opioid system contributes to cognitive deficits and other behavioral abnormalities associated with psychiatric disorders are warranted.
Citations in the library
Cited by 7
- Animal Models of Serotonergic Psychedelics ACS Chemical Neuroscience September 24, 2012
- Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A. Pharmacological Reviews June 1, 2011
- Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects Pharmaceuticals February 3, 2021
- Learning and memory impairment induced by salvinorin A, the principal ingredient of Salvia divinorum, in wistar rats. International journal of toxicology December 1, 2011
- The translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies. Translational Psychiatry October 10, 2025
and 2 more in the library
Cites 4
- Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences September 3, 2002
- Toxic Psychosis After Intake of the Hallucinogen Salvinorin A The Journal of Clinical Psychiatry September 30, 2008
- Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. Journal of Pharmacology and Experimental Therapeutics January 2006
- Psychotomimesis mediated by kappa opiate receptors. Science August 15, 1986